Nabriva requests FDA meeting to ‘gain clarity’ on agency's April vote
June 19, 2019 at 11:48 AM EDT
The FDA turned down Nabriva’s new drug application for its experimental urinary tract infection antibiotic in April.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|